Postoperative Cognitive DysfunctionSOMEDYSPONCT04481347
Relationship Between Sleep EEG, Intraoperative EEG and Postoperative Cognitive Dysfunction
An observational study of Postoperative Cognitive Dysfunction, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
The challenge of new recommendations and better adapted practices is pushing to operate patients who are getting older and more fragile. In this context, there is an inevitable increase in the risks associated with care and in particular perioperative neurological complications, of which postoperative cognitive… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Postoperative Cognitive Dysfunction
- What is being tested?
- Sleep EEG recording using a DREEM® headband, Montreal Cognitive Assessment (MoCA) and Intraoperative EEG recording using a Sedline® monitoring
- Type of treatment
- Medical device
- How many people
- 66 participants
- Where
- 1 siteFrance
- Study dates
- 15 Jul 2020to 21 Feb 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients eligible for a non-emergency scheduled interventional neuroradiology procedure or surgery performed under general anesthesia.
Who may be able to join
- Major patients (≥ 18 years )
- Eligible for an interventional radiology procedure or surgery under general anesthesia
- Patients informed and having expressed their non-opposition to participation in this research
Who cannot join
- Patients under 18 years old
- Severe pre-existing cognitive impairment (preoperative mini-mental state examination (MMSE) < 24)
- Patient opposed to protocol participation
- Pregnant woman
- Patient under judicial protection
- Patient without affiliation to a social security scheme
- Emergency procedure
Trial locations and contacts
1 site in 1 country.
France1 site
AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care
Paris, 75010
About this study
The challenge of new recommendations and better adapted practices is pushing to operate patients who are getting older and more fragile. In this context, there is an inevitable increase in the risks associated with care and in particular perioperative neurological complications, of which postoperative cognitive dysfunction (POCD) is the most common.
The interest of perioperative cerebral monitoring and in particular electroencephalography (EEG) to reduce neurological and cognitive damage in surgery has been the subject of abundant research and corresponds to a crucial issue.
Read more
From the literature and preliminary results obtained in our clinical research unit, it appears that there is also a relationship between certain characteristics of the peroperative EEG (signal strength and burst suppression) and the occurrence of postoperative cognitive dysfunction (PCOD).
In this context, quantitative analysis of the preoperative sleep EEG and the EEG obtained during general anesthesia could allow the identification of a simple to use biomarker of susceptibility or fragility. To our knowledge, there is no preoperative evaluation strategy using EEG analysis to detect a predisposition to POCD.
The main goal of this observational clinical study is to extend the traditional use of per-operative EEG with pre-operative and post-operative sleep EEG for the detection and prediction of early post-operative cognitive dysfunction.
Read the detailed description
The interest of perioperative brain monitoring to reduce neurological and cognitive damage in surgery has been the subject of much research and corresponds to a crucial issue.
The notion of quantitative EEG covers all the electrical signal processing techniques (fast Fourier transformation, evoked potentials, EEG mapping, etc.) made possible through the digitization of EEG data and the development of software to process these signals. In this context, EEG-derived indices have been set up to monitor hypnosis during general anesthesia. Between 0 (deep hypnosis) and 100 (awakening), the Bispectral Index (BIS) integrates in its calculation the percentage of fast waves, the degree of wave synchronization and the periods of EEG suppression (or "Burst suppression") and allows an adaptation of the dosage of anesthetic products according to its value.
Avoiding too deep anesthesia through neuro-monitoring could help to reduce postoperative delirium by reducing the burst suppression pattern.
Pre-operative cognitive status assessment :
The investigators observe a great delay in the means implemented to have an objective evaluation of cognitive disorders in preoperative care.
One of the pitfalls of our anesthetist specialty is the lack of continuity of medical care in the perioperative period.
The geriatric evaluation including a MMSE (mental mini state examination) and a MoCA (Montreal cognitive assessment) is performed only occasionally.
Interest of the resting pre-operative EEG :
Sleep EEG analysis is already used in cognitive studies. Slow Wave Activity (SWA) is a parameter known to be inversely correlated with chronological age and lowered more significantly in the context of cognitive dysfunction.
The power of spindles or sleep spindles and particularly fast spindles have been shown to be potentially predictive of poor cognitive development in patients already showing symptoms (Mild Cognitive Impairment).
It is likely that per operative susceptibility to Burst suppression and the appearance of postoperative cognitive dysfunction are linked to a set of per operative factors (anesthesia, surgery, inflammation, pain...) but also preoperative factors (cognitive state, physiological age and cerebral fragility...).
The investigators hypothesize that there is an association between preoperative resting EEG abnormalities and the risk of postoperative cognitive dysfunction.
The goal of this observational clinical study is to assess the fragility of a patient under general anesthesia and based on the perioperative quantitative analysis EEG. Thus, this project should help specialists in perioperative medicine to identify patients at risk of cognitive dysfunction and could lead to proposing strategies for its prevention.
Measures are based on neuro-psychological tests (Montreal cognitive assesment -MoCA) and EEG signal and subfrequency power spectral densities including alpha band as well as the amount of Propofol, each measured for EEG periods where SEF 95 = 8-13Hz.
Analysis includes the characteristics of the preoperative sleep EEG (SWA, fast spindles).
Experimental design: This is a single-center, observational prospective study.
Population concerned :
Patients eligible for interventional neuroradiology or surgery performed under General Anesthesia are selected to participate in this prospective, observational, single-center, routine care study. Patients will be included if they received, for a non-urgent scheduled procedure.
Patients over 18 years of age are eligible to participate in this protocol. During the anesthesia consultation, they will be given a hand-delivered letter of information on the objectives and the course of the study. Their non-opposition to participating in this study will be collected at the latest during the pre-anesthetic visit, on the eve of the operation after a period of reflection.
The protocol will start the day before the intervention. The interventions will be performed under general anaesthesia. The protocol does not interact with the care procedure. All the measures are obtained non-invasively.
The day before the procedure: performance of a sleep EEG (DREEM®) and a MoCA test. On the day of the procedure, monitoring of the depth of anesthesia using the quantitative EEG (Sedline Masimo®) ensures continuous recording of intraoperative EEG data. Postoperatively the same investigator performs MoCA at Day1, Day2 and Day5. A sleep EEG (DREEM®) is performed at Day2 and Day5 if the patient is still hospitalized.
During their general anesthesia, all patients' routine monitoring will consist in collecting the following parameters: electrocardiogram, pulsated oxygen saturation, endtidal CO2, respiratory rate, tidal volume and neuromuscular function.
For all patients whatever the comorbidities, anesthesia induction will be performed using a target-controlled infusion (Orchestra® Base Primea - Fresenius Kabi France).
No additional additional examination will be performed. The anesthetic strategy is decided by the anesthetist in charge of the procedure.
The doctor in charge of the study collecting the data does not interfere at any time in the management of the patient. The measurements cannot influence the prescribing physician since at this stage the data are not yet analysed and available.
Number of selected subjects: Assuming an incidence of DCPO of 30%, with power at 80% and alpha risk at 5%, it is necessary to include 100 patients to demonstrate an area under the ROC curve of 80% with a confidence interval width of 0.1
Statistics:
Continuous data will be expressed in median [interquartile] and qualitative data in n (%). Categorical variables will be compared by Mann-Whitney test and continuous variables by Wilcoxon test.
In this study, the primary endpoint was the occurrence of post-operative cognitive dysfunction, defined as a decrease in MoCA score of more than 4 points between preoperative and postoperative periods (worst value of the score measured at D1, D2 and D5). The main exposure is the quantitative score obtained from the analysis of the pre-operative sleep EEG.
The ability of the various parameters of interest of the preoperative sleep EEG to predict the occurrence of DCPO will be estimated by constructing an ROC curve. The area of these ROC curves will be measured and the corresponding 95% confidence interval estimated. The areas under the ROC curve of the different parameters will be compared by DeLong test. A uni- and then multivariate analysis will be performed to identify the clinical parameters associated with the occurrence of a DCPO. The possible added value of the sleep EEG parameters on the clinical parameters will be evaluated by reclassification techniques.
The statistical analysis will be carried out using the statistical analysis software "R" (The R Foundation, Vienna, Austria)
- Conditions
- Postoperative Cognitive Dysfunction
- Being tested
- Sleep EEG recording using a DREEM® headband, Montreal Cognitive Assessment (MoCA), Intraoperative EEG recording using a Sedline® monitoring
- Keywords
- postoperative cognitive dysfunction, depth of anesthesia, brain fragility, electrographic suppression
- Medical subject headings
- Postoperative Cognitive Complications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sleep EEG recording using a DREEM® headbandDevice
Sleep EEG recording using a Dreem® headband (Rythm, Paris, France), an EEG recording device adapted to sleep conditions and completely non-invasive
Montreal Cognitive Assessment (MoCA)Other
Neuropsychological assessment using the The Montreal Cognitive Assessment (MoCA) questionnaire to detect postoperative cognitive dysfunction
Intraoperative EEG recording using a Sedline® monitoringDevice
Intraoperative brain function monitoring using a Sedline® module (Masimo corporation) to evaluate the state of the brain under anesthesia
| Study group | Role | What they receive |
|---|---|---|
| Patients undergoing general anesthesia | Patients eligible for interventional neuroradiology or surgery performed under general anesthesia. Patients will be included if they are admitted for a non-emergency scheduled procedure. Receives: Device: Sleep EEG recording using a DREEM® headband; Other: Montreal Cognitive Assessment (MoCA); Device: Intraoperative EEG recording using a Sedline® monitoring |
What is being measured
The primary outcome is the main question the study is designed to answer.
Early postoperative cognitive dysfunction
Score obtained following evaluation of the patient's cognitive function using the Montreal Cognitive Assessment questionnaire MoCA (0-30; higher score indicates better performance)
Measured: Change between day -1 and day 5
Secondary outcomes (4)
Burst suppression duration
For all patients the values of Burst Suppression (in % of time) will be collected from frontal electrodes montage (Fp1, Fp2, F7, F8) during the total anesthesia period (induction and hypnotic periods)
Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)
Variations in alpha power on sleep EEG
Variations in alpha power (in Decibel, Db) on the pre-operative and post-operative sleep EEG
Measured: Change between day -1 and day 5
Spindle amplitude on sleep EEG
Spindle amplitude (in Decibel, Db) on preoperative and postoperative sleep EEG
Measured: Change between day -1 and day 5
Spindle frequency on sleep EEG
Spindle frequency (in Hertz, Hz) on preoperative and postoperative sleep EEG
Measured: Change between day -1 and day 5
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jul 2020
- Study start15 Jul 2020
- Primary completion21 Feb 2022
- Study completion21 Feb 2022
Why it stopped: Difficulties in recruiting patients
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Postoperative Cognitive DysfunctionStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 66 participants (actual)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Collaborators
- INSERM UMR-942, Paris, France, LMS Ecole polytechnique and M3DISIM, Inria
- Responsible party
- Sponsor
- Investigators
- Joaquim MATEO, MD, Study director, Assistance Publique - Hôpitaux de ParisFabrice VALLEE, MD, Principal investigator, Assistance Publique - Hôpitaux de Paris
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04481347
- Sponsor's protocol ID
- APHP200037
- Other IDs
- 2019-A03206-51
- Acronym
- SOMEDYSPO
- Status last verified
- Sep 2026
- First submitted
- 23 Jun 2020
- Last updated
- 22 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Relationship Between Sleep EEG, Intraoperative EEG and Postoperative Cognitive Dysfunction
- ClinicalTrials.gov ID
- NCT04481347
- Acronym / sponsor ID
- SOMEDYSPO / APHP200037
- Conditions
- Postoperative Cognitive Dysfunction
- Keywords
- postoperative cognitive dysfunction, depth of anesthesia, brain fragility, electrographic suppression
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: Difficulties in recruiting patients
- Enrolment
- 66 participants (actual)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Collaborators
- INSERM UMR-942, Paris, France, LMS Ecole polytechnique and M3DISIM, Inria
- Study start
- 15 Jul 2020 (actual)
- Primary completion
- 21 Feb 2022 (actual)
- Study completion
- 21 Feb 2022 (actual)
- First posted
- 22 Jul 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The challenge of new recommendations and better adapted practices is pushing to operate patients who are getting older and more fragile. In this context, there is an inevitable increase in the risks associated with care and in particular perioperative neurological complications, of which postoperative cognitive dysfunction (POCD) is the most common.
The interest of perioperative cerebral monitoring and in particular electroencephalography (EEG) to reduce neurological and cognitive damage in surgery has been the subject of abundant research and corresponds to a crucial issue.
From the literature and preliminary results obtained in our clinical research unit, it appears that there is also a relationship between certain characteristics of the peroperative EEG (signal strength and burst suppression) and the occurrence of postoperative cognitive dysfunction (PCOD).
In this context, quantitative analysis of the preoperative sleep EEG and the EEG obtained during general anesthesia could allow the identification of a simple to use biomarker of susceptibility or fragility. To our knowledge, there is no preoperative evaluation strategy using EEG analysis to detect a predisposition to POCD.
The main goal of this observational clinical study is to extend the traditional use of per-operative EEG with pre-operative and post-operative sleep EEG for the detection and prediction of early post-operative cognitive dysfunction.
Detailed description
The interest of perioperative brain monitoring to reduce neurological and cognitive damage in surgery has been the subject of much research and corresponds to a crucial issue.
The notion of quantitative EEG covers all the electrical signal processing techniques (fast Fourier transformation, evoked potentials, EEG mapping, etc.) made possible through the digitization of EEG data and the development of software to process these signals. In this context, EEG-derived indices have been set up to monitor hypnosis during general anesthesia. Between 0 (deep hypnosis) and 100 (awakening), the Bispectral Index (BIS) integrates in its calculation the percentage of fast waves, the degree of wave synchronization and the periods of EEG suppression (or "Burst suppression") and allows an adaptation of the dosage of anesthetic products according to its value.
Avoiding too deep anesthesia through neuro-monitoring could help to reduce postoperative delirium by reducing the burst suppression pattern.
Pre-operative cognitive status assessment :
The investigators observe a great delay in the means implemented to have an objective evaluation of cognitive disorders in preoperative care.
One of the pitfalls of our anesthetist specialty is the lack of continuity of medical care in the perioperative period.
The geriatric evaluation including a MMSE (mental mini state examination) and a MoCA (Montreal cognitive assessment) is performed only occasionally.
Interest of the resting pre-operative EEG :
Sleep EEG analysis is already used in cognitive studies. Slow Wave Activity (SWA) is a parameter known to be inversely correlated with chronological age and lowered more significantly in the context of cognitive dysfunction.
The power of spindles or sleep spindles and particularly fast spindles have been shown to be potentially predictive of poor cognitive development in patients already showing symptoms (Mild Cognitive Impairment).
It is likely that per operative susceptibility to Burst suppression and the appearance of postoperative cognitive dysfunction are linked to a set of per operative factors (anesthesia, surgery, inflammation, pain...) but also preoperative factors (cognitive state, physiological age and cerebral fragility...).
The investigators hypothesize that there is an association between preoperative resting EEG abnormalities and the risk of postoperative cognitive dysfunction.
The goal of this observational clinical study is to assess the fragility of a patient under general anesthesia and based on the perioperative quantitative analysis EEG. Thus, this project should help specialists in perioperative medicine to identify patients at risk of cognitive dysfunction and could lead to proposing strategies for its prevention.
Measures are based on neuro-psychological tests (Montreal cognitive assesment -MoCA) and EEG signal and subfrequency power spectral densities including alpha band as well as the amount of Propofol, each measured for EEG periods where SEF 95 = 8-13Hz.
Analysis includes the characteristics of the preoperative sleep EEG (SWA, fast spindles).
Experimental design: This is a single-center, observational prospective study.
Population concerned :
Patients eligible for interventional neuroradiology or surgery performed under General Anesthesia are selected to participate in this prospective, observational, single-center, routine care study. Patients will be included if they received, for a non-urgent scheduled procedure.
Patients over 18 years of age are eligible to participate in this protocol. During the anesthesia consultation, they will be given a hand-delivered letter of information on the objectives and the course of the study. Their non-opposition to participating in this study will be collected at the latest during the pre-anesthetic visit, on the eve of the operation after a period of reflection.
The protocol will start the day before the intervention. The interventions will be performed under general anaesthesia. The protocol does not interact with the care procedure. All the measures are obtained non-invasively.
The day before the procedure: performance of a sleep EEG (DREEM®) and a MoCA test. On the day of the procedure, monitoring of the depth of anesthesia using the quantitative EEG (Sedline Masimo®) ensures continuous recording of intraoperative EEG data. Postoperatively the same investigator performs MoCA at Day1, Day2 and Day5. A sleep EEG (DREEM®) is performed at Day2 and Day5 if the patient is still hospitalized.
During their general anesthesia, all patients' routine monitoring will consist in collecting the following parameters: electrocardiogram, pulsated oxygen saturation, endtidal CO2, respiratory rate, tidal volume and neuromuscular function.
For all patients whatever the comorbidities, anesthesia induction will be performed using a target-controlled infusion (Orchestra® Base Primea - Fresenius Kabi France).
No additional additional examination will be performed. The anesthetic strategy is decided by the anesthetist in charge of the procedure.
The doctor in charge of the study collecting the data does not interfere at any time in the management of the patient. The measurements cannot influence the prescribing physician since at this stage the data are not yet analysed and available.
Number of selected subjects: Assuming an incidence of DCPO of 30%, with power at 80% and alpha risk at 5%, it is necessary to include 100 patients to demonstrate an area under the ROC curve of 80% with a confidence interval width of 0.1
Statistics:
Continuous data will be expressed in median [interquartile] and qualitative data in n (%). Categorical variables will be compared by Mann-Whitney test and continuous variables by Wilcoxon test.
In this study, the primary endpoint was the occurrence of post-operative cognitive dysfunction, defined as a decrease in MoCA score of more than 4 points between preoperative and postoperative periods (worst value of the score measured at D1, D2 and D5). The main exposure is the quantitative score obtained from the analysis of the pre-operative sleep EEG.
The ability of the various parameters of interest of the preoperative sleep EEG to predict the occurrence of DCPO will be estimated by constructing an ROC curve. The area of these ROC curves will be measured and the corresponding 95% confidence interval estimated. The areas under the ROC curve of the different parameters will be compared by DeLong test. A uni- and then multivariate analysis will be performed to identify the clinical parameters associated with the occurrence of a DCPO. The possible added value of the sleep EEG parameters on the clinical parameters will be evaluated by reclassification techniques.
The statistical analysis will be carried out using the statistical analysis software "R" (The R Foundation, Vienna, Austria)
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients undergoing general anesthesia | – | Device: Sleep EEG recording using a DREEM® headband, Other: Montreal Cognitive Assessment (MoCA), Device: Intraoperative EEG recording using a Sedline® monitoringPatients eligible for interventional neuroradiology or surgery performed under general anesthesia. Patients will be included if they are admitted for a non-emergency scheduled procedure. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients eligible for a non-emergency scheduled interventional neuroradiology procedure or surgery performed under general anesthesia.
Key inclusion criteria (3 listed)
- Major patients (≥ 18 years )
- Eligible for an interventional radiology procedure or surgery under general anesthesia
- Patients informed and having expressed their non-opposition to participation in this research
Key exclusion criteria (7 listed)
- Patients under 18 years old
- Severe pre-existing cognitive impairment (preoperative mini-mental state examination (MMSE) < 24)
- Patient opposed to protocol participation
- Pregnant woman
- Patient under judicial protection
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sleep EEG recording using a DREEM® headbandSleep EEG recording using a Dreem® headband (Rythm, Paris, France), an EEG recording device adapted to sleep conditions and completely non-invasive | Device | Patients undergoing general anesthesia |
| Montreal Cognitive Assessment (MoCA)Neuropsychological assessment using the The Montreal Cognitive Assessment (MoCA) questionnaire to detect postoperative cognitive dysfunction | Other | Patients undergoing general anesthesia |
| Intraoperative EEG recording using a Sedline® monitoringIntraoperative brain function monitoring using a Sedline® module (Masimo corporation) to evaluate the state of the brain under anesthesia | Device | Patients undergoing general anesthesia |
Primary outcome
Early postoperative cognitive dysfunction
Time frame: Change between day -1 and day 5
Score obtained following evaluation of the patient's cognitive function using the Montreal Cognitive Assessment questionnaire MoCA (0-30; higher score indicates better performance)
4 secondary outcomes
Burst suppression duration
Time frame: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)
Variations in alpha power on sleep EEG
Time frame: Change between day -1 and day 5
Spindle amplitude on sleep EEG
Time frame: Change between day -1 and day 5
Spindle frequency on sleep EEG
Time frame: Change between day -1 and day 5
Results and safety
The study was stopped early (reason given: Difficulties in recruiting patients). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Sep 2026.
Related trials for Postoperative Cognitive Dysfunction
Enrolling by invitationPhase 4
Effects of Ciprofol on Perioperative Neurocognitive Function in Elderly Patients Undergoing Daytime Surgery
PND, POCD - Postoperative Cognitive Dysfunction
Not yet recruitingObservational study
Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery
Postoperative Cognitive Complications, Delirium
Not yet recruitingObservational study
Postsurgical Pain and Opioid Use in Older Adults: Effects of Mild Cognitive Impairment
Mild Cognitive Impairment (MCI), Opioid Use
Not yet recruitingObservational study
Impact of Preoperative Mild Cognitive Impairment on Postoperative Delirium in Patients Undergoing Cardiac Surgery
Neurocognitive Disorder, Cardiac Surgery
RecruitingObservational study
Post Operative Cognitive Dysfunction After Oncologic Surgery
Emergence Delirium, Post-Operative Cognitive Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Joaquim MATEO, MD study director
Assistance Publique - Hôpitaux de Paris
Fabrice VALLEE, MD principal investigator
Assistance Publique - Hôpitaux de Paris
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Postoperative Cognitive Dysfunction, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Difficulties in recruiting patients). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Early postoperative cognitive dysfunction (time frame: Change between day -1 and day 5). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.